Cargando…
Arbekacin as an Alternative Drug to Teicoplanin for the Treatment of MRSA Infection
Autores principales: | Hwang, Ji-Hee, Lee, Ju-Hyung, Kim, Ju-Sin, Hwang, Jeong-Hwan, Lee, Chang-Seop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951450/ https://www.ncbi.nlm.nih.gov/pubmed/27189305 http://dx.doi.org/10.3349/ymj.2016.57.4.1047 |
Ejemplares similares
-
The Efficacy and Safety of Arbekacin and Vancomycin for the Treatment in Skin and Soft Tissue MRSA Infection: Preliminary Study
por: Hwang, Ji-Hee, et al.
Publicado: (2013) -
Comparison of Arbekacin and Vancomycin in Treatment of Chronic Suppurative Otitis Media by Methicillin Resistant Staphylococcus aureus
por: Hwang, Ji-Hee, et al.
Publicado: (2015) -
Clinical Usefulness of Arbekacin
por: Lee, Jae Hoon, et al.
Publicado: (2016) -
The usefulness of arbekacin compared to vancomycin
por: Hwang, J.-H., et al.
Publicado: (2011) -
Appropriate oral antibiotics for bone and joint infections based on the susceptibility of clinical Staphylococcus aureus isolates
por: Lee, Chang-Seop, et al.
Publicado: (2015)